Figure 1From: Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial The median PFS time was 12 months, and 1- year PFS rate 49 .4%. Back to article page